Fenofibrate to prevent nerve damage from multiple myeloma treatment
Treatments studied
Part of Blood & lymphatic, Brain & nervous system, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This trial tests if adding fenofibrate to standard treatment (VRd) can prevent nerve damage (peripheral neuropathy) caused by bortezomib in patients with newly diagnosed multiple myeloma. If you are starting VRd therapy, this study may help reduce pain or numbness from the chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been newly diagnosed with multiple myeloma and are about to start treatment with VRd (bortezomib, lenalidomide, dexamethasone)
- You are in generally good physical condition (ECOG score less than 2, meaning you can do most daily activities)
- Your blood counts (neutrophils, platelets, hemoglobin) and liver/kidney function are within normal limits
- You have not used certain other nerve-toxic drugs or supplements (like high-dose vitamins A, C, E) recently, and you do not have pre-existing nerve damage from diabetes or other causes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether ketotifen can protect against nerve damage (called peripheral neuropathy) caused by oxaliplatin, a common chemotherapy used for stage III colon cancer. If it works, it may help reduce tingling, numbness, or burning pain in the hands and feet.
This trial tests whether two common medications, memantine and rosuvastatin, can protect nerves during colorectal cancer treatment. If you are about to start chemotherapy with FOLFOX or XELOX, this study may help reduce nerve damage.
This trial tests whether taking coenzyme Q10 (a natural substance) can help prevent nerve damage caused by the chemotherapy drug oxaliplatin in people with stage III colorectal cancer. If successful, it could reduce pain, numbness, or tingling during treatment.
This trial tests if taking fish oil can help prevent nerve pain and numbness caused by the chemotherapy drug bortezomib in people with multiple myeloma. It combines data analysis, lab work, and a clinical study to find out.
This trial tests a new combination of drugs—linperlisib plus the standard VRD regimen (bortezomib, lenalidomide, and dexamethasone)—for people newly diagnosed with multiple myeloma who are eligible for a stem cell transplant. The goal is to see if adding linperlisib can improve treatment outcomes.
This trial tests a combination of three drugs (isatuximab, bortezomib, lenalidomide, and a steroid) for people with newly diagnosed multiple myeloma who are older or frail and cannot have a stem cell transplant. It focuses on those with a certain type of myeloma cell in their blood, to see if the treatment works well and is safe.
Hear when a new Peripheral Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.